MedTrace Logo

Antimicrobial Susceptibility for Helicobacter Pylori Eradication

NCT01486082 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2011-12-13

No results posted yet for this study

Summary

Due to the high rate of resistance to clarithromycin in our area the investigators proposed an study to assess the need of antibiogram previous to the empirical OCA 10 treatment, in order to improve the rate of eradication.

Conditions

  • Helicobacter Pylori Infection

Interventions

OTHER

OCA 10

A group will be treated with omeprazole (20 mg / 12 h), amoxicillin (1 g/ 12 h)and clarithromycin (500 mg/12 h) for 10 days (as following current guides) without having a previous antibiogram, and the other group will be treated after antibiotic susceptibility.

Sponsors & Collaborators

  • Hospital Donostia

    lead OTHER

Principal Investigators

  • LUIS BUJANDA

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2011-11-30
Completion
2012-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01486082 on ClinicalTrials.gov